Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma

Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma

Thomas A Ollila,1,2 Adam J Olszewski1,2 1Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA; 2Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USACorrespondence: Adam J OlszewskiDepartment of Medicine, Alpert Medical School of Brown Universi...

Full description

Bibliographic Details
Main Authors:	Ollila TA, Olszewski AJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-05-01
Series:	Cancer Management and Research
Subjects:	follicular lymphoma marginal zone lymphoma geriatric oncology lenalidomide ibritumomab tiuxetan bispecific antibodies
Online Access:	https://www.dovepress.com/chemotherapy-free-management-of-follicular-and-marginal-zone-lymphoma-peer-reviewed-fulltext-article-CMAR

Similar Items

Failure of yttrium-90 (90Y)-ibritumomab tiuxetan radioimmunotherapy (Zevalin®) with fatal side effects in relapsed/refractory diffuse large B-cell NHL transformed from other lymphomas
by: Songül Şerefhanoğlu, et al.
Published: (2008-12-01)

Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada
by: John Kuruvilla, et al.
Published: (2023-04-01)

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
by: Andrea Rivero, et al.
Published: (2023-05-01)

Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab
by: Lopedote P, et al.
Published: (2023-03-01)

Modern approaches to the treatment of relapsed follicular lymphoma
by: Yu. E. Ryabukhina, et al.
Published: (2022-07-01)

Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma
by: Yang Liu, et al.
Published: (2024-04-01)

Synchronous immunophenotypically and clonally distinct follicular lymphoma and marginal zone lymphoma with massive amyloid deposition
by: Ariel S. Frost, et al.
Published: (2016-09-01)

Analisi costi-efficacia di 90Y-ibritumomab tiuxetano (Zevalin®) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato
by: Carlo Lazzaro, et al.
Published: (2005-12-01)

Immunotherapy beyond cellular therapy in follicular lymphoma: A case of complete remission after failure of two CAR‐T
by: Adam M. Kase, et al.
Published: (2022-04-01)

Radiotherapy in marginal zone lymphoma
by: Deinbeck Kristin, et al.
Published: (2013-01-01)

Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy
by: Robin Jacob, MD, et al.
Published: (2020-11-01)

PD1hi cells associate with clusters of proliferating B-cells in marginal zone lymphoma
by: Katherine Wickenden, et al.
Published: (2018-09-01)

Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting
by: Zhijuan Lin, et al.
Published: (2023-04-01)

Primary marginal zone B-cell lymphoma of appendix
by: Radha S, et al.
Published: (2008-07-01)

Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatmentResearch in context
by: Luca Arcaini, et al.
Published: (2024-06-01)

Skin lesions as the first manifestation of follicular lymphoma
by: Julia Nowowiejska, et al.
Published: (2023-11-01)

Pediatric-type follicular lymphoma
by: Anuj Verma, et al.
Published: (2022-03-01)

Exclusive surgical treatment of a primary cutaneous marginal zone lymphoma: a case report
by: Elisa Nunes Secamilli, et al.
Published: (2022-12-01)

An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement
by: Andrew J. Sunderland, et al.
Published: (2020-01-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
by: Han-Na Kim, et al.
Published: (2022-01-01)

Primary cutaneous marginal zone lymphoma
by: Ali Gokkaya, et al.
Published: (2021-01-01)

Primary cutaneous marginal zone lymphoma (immunocytoma like) with lymphoepithelioid or Lennert′s lymphoma like involvement of nodes
by: Tanuja Shet, et al.
Published: (2012-01-01)

Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
by: Dominic Kaddu-Mulindwa, et al.
Published: (2022-06-01)

Primary testicular follicular lymphoma
by: Sofia Garces, et al.
Published: (2022-03-01)

Advances in the treatment of relapsed/refractory marginal zone lymphoma
by: Haotian Wang, et al.
Published: (2024-01-01)

Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential
by: Jacob E. Robinson, et al.
Published: (2020-05-01)

Rosettes: An Additional Clue for the Identification of the Primary Cutaneous Marginal Zone Lymphoma
by: Maria Eugenia Gil, et al.
Published: (2023-07-01)

Marginal zone lymphoma presenting in a patient with autoimmune hemolytic anemia: a case report
by: Büşra Güner, et al.
Published: (2023-01-01)

Supplementum 216: Diagnosis and treatment of marginal zone lymphoma
by: Sergio Cogliatti, et al.
Published: (2016-08-01)

Dermatological Considerations in the Diagnosis and Treatment of Marginal Zone Lymphomas
by: Ronchi A, et al.
Published: (2021-03-01)

Primary extranodal marginal zone lymphoma - Epididymis
by: Shanmugasundaram Rajaian, et al.
Published: (2011-01-01)

Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges
by: Tayse Silva dos Santos, et al.

A rare face of follicular lymphoma: reverse variant of follicular lymphoma
by: Ninu Maskey, et al.
Published: (2020-04-01)

In situ follicular neoplasia/lymphoma: Three illustrative cases exemplifying unique disease presentations
by: Uma Sakhadeo, et al.
Published: (2012-01-01)

Can bispecific antibodies change the paradigm and goals of therapy for patients with relapsed non-Hodgkin lymphomas?
by: Irina V. Poddubnaya
Published: (2023-12-01)

Intralesional Corticosteroids for Long-term Control of Primary Cutaneous Marginal Zone Lymphoma without systemic involvement
by: Pragya Tiwari, et al.
Published: (2019-07-01)

Extranodal Ocular Adnexal Marginal Zone Lymphoma in a Ten-Year-Old Child
by: Nazan Çetingül, et al.
Published: (2020-01-01)

SJOGREN SYNDROME AND PAROTID MARGINAL ZONE LYMPHOMA: REPORT OF A CASE AND REVIEW OF LITERATURE.
by: Francesco Lorusso
Published: (2020-04-01)

Radiotherapy for early and advanced stages Follicular Lymphoma
by: Geovanne Pedro Mauro, et al.
Published: (2021-01-01)

Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomy
by: Márcio Debiasi, et al.